News from REMEDY

Ahead of the professorship celebration in December 2025, she was asked to reflect on the path to getting there – and where the subject is headed next.

What should arthritis research focus on going forward? In a new study, patients and healthcare professionals have collaborated to identify the ten most important questions for research in the field. At the top of the list is prevention.

Many people know psoriasis as a skin disease, but it can also affect the joints. About one in ten people with psoriasis develop psoriatic arthritis, which causes pain, swelling and stiffness in the joints. Today we mark World Psoriasis Day.

Hilde Berner Hammer has been a driving force in the development of modern rheumatology in Norway for decades. She is internationally recognized as one of the world's leading experts on the use of ultrasound in rheumatological diseases and has led groundbreaking projects such as NOR-CACTUS and the work on precision medicine at the REMEDY Center.

The START study at Diakonhjemmet Hospital has reached an important milestone: One hundred patients with newly diagnosed arthritis have now been included. The milestone shows that the project is progressing as planned. The goal is to find signs in patients that can be used for 1) early diagnosis, 2) personalized treatment and 3) appropriate follow-up for the individual.

More than 60 leading researchers, clinicians and patient representatives from Europe are gathered in Oslo. REMEDY at Diakonhjemmet Hospital is hosting the general assembly of the EU-funded project SQUEEZE. The project aims to make the treatment of arthritis and similar diseases more accurate and effective.

Researchers, professionals and patients met at Diakonhjemmet Hospital to share new insights in the field of rheumatology. The dialogue seminar on September 23rd had the main theme of medications and coping. Ingvild Kjeken and Anna Fryxelius guided us through the program. They also ensured that questions from the audience were well attended to.